Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6281075 | 0.98 | FBP1 (0.43) | FBP1NPC1RAB9APTGS2HPGD | |
| SCHEMBL3777146 | 0.94 | FBP1 (0.46) | FBP1NPC1RAB9APTGS2HPGD | |
| SCHEMBL621756 | 0.86 | — | — | |
| SCHEMBL9724074 | 0.81 | FBP1 (0.45) | FBP1NPC1RAB9APTGS2HPGD | |
| SCHEMBL5315566 | 0.79 | FBP1 (0.43) | FBP1PTGS2HPGDMAPTALDH1A1 | |
| SCHEMBL28390983 | 0.79 | FBP1 (0.43) | FBP1PTGS2HPGDMAPTALDH1A1 | |
| SCHEMBL6277977 | 0.79 | CA2 (0.44) | FBP1NPC1RAB9AHPGDMAPT | |
| SCHEMBL20669518 | 0.79 | FBP1 (0.43) | FBP1PTGS2HPGDMAPTALDH1A1 | |
| SCHEMBL27916875 | 0.79 | FBP1 (0.43) | FBP1PTGS2HPGDMAPTALDH1A1 | |
| SCHEMBL17372958 | 0.79 | FBP1 (0.43) | FBP1PTGS2HPGDMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861496-B2 | Polyhydroxyalkonoate and method of producing same, and ω-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2005-03-01 | — | — | US | disclosed |
| US-6855472-B2 | POLYHYDROXYALKANOATE, PRODUCING METHOD THEREFOR, CHARGE CONTROL AGENT CONTAINING SUCH POLYHYDROXYALKANOATE, TONER CONTAINING SUCH CONTROL AGENT AND IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS UTILIZING SUCH TONER | CANON KABUSHIKI KAISHA (JP) | 2005-02-15 | — | — | US | disclosed |
| EP-1236754-B1 | Polyhydroxyalkanoate and method of producing the same, and omega-(2-thienylsulfanyl)alkanoic acid and method of producing the same | CANON KK (JP) | 2004-04-28 | — | — | EP | disclosed |
| US-20040062811-A1 | Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA | 2004-04-01 | — | — | US | disclosed |
| US-6686439-B2 | POLYHYDROXYALKANOATE FOR USE IN CULTURING MICROORGANISMS | CANON KABUSHIKI KAISHA (JP) | 2004-02-03 | — | — | US | disclosed |
| US-20030073804-A1 | Polyhydroxyalkanoate, producing method therefor charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner | CANON KABUSHIKI KAISHA (JP) | 2003-04-17 | — | — | US | disclosed |
| US-20020164726-A1 | Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-1254918-A2 | Novel polyhydroxyalkanoate, producing method therefor, charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner | CANON KABUSHIKI KAISHA (JP) | 2002-11-06 | — | — | EP | disclosed |
| EP-1236754-A2 | Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062811-A1 | Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | HACL2, PAH, TST | FBP1 1071/4885NPC1 4038/4885RAB9A 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.